---
title: "Roth MKM 維持對 LB Pharmaceuticals, Inc.（LBRX）的買入評級"
description: "Roth MKM 分析師 Boobalan Pachaiyappan 對 LB Pharmaceuticals, Inc. (LBRX) 維持了買入評級，目標價為 31.00 美元。該分析師專注於醫療保健行業，推薦的平均回報率為 6.3%，成功率為 45.30%。對 LB Pharmaceuticals 的共識評級為強烈買入，平均目標價為 48.00 美元"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/273861458.md"
published_at: "2026-01-27T14:55:59.000Z"
---

# Roth MKM 維持對 LB Pharmaceuticals, Inc.（LBRX）的買入評級

> Roth MKM 分析師 Boobalan Pachaiyappan 對 LB Pharmaceuticals, Inc. (LBRX) 維持了買入評級，目標價為 31.00 美元。該分析師專注於醫療保健行業，推薦的平均回報率為 6.3%，成功率為 45.30%。對 LB Pharmaceuticals 的共識評級為強烈買入，平均目標價為 48.00 美元

Roth MKM 分析師 Boobalan Pachaiyappan 今天對 LB Pharmaceuticals, Inc. 維持了買入評級，並設定了 31.00 美元的目標價。

### 申請 50% 折扣 TipRanks Premium

-   解鎖對沖基金級別的數據和強大的投資工具，以做出更聰明、更精準的決策
-   通過最新的新聞和分析保持市場領先，最大化您的投資組合潛力

Pachaiyappan 關注醫療保健行業，重點關注 Capricor Therapeutics、PolyPid 和 CervoMed 等股票。根據 TipRanks，Pachaiyappan 推薦股票的平均回報率為 6.3%，成功率為 45.30%。

目前，分析師對 LB Pharmaceuticals, Inc. 的共識評級為強烈買入，平均目標價為 48.00 美元。

### Related Stocks

- [LBRX.US - LB Pharmaceuticals](https://longbridge.com/zh-HK/quote/LBRX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| LB Pharmaceuticals, Inc. (LBRX) Receives a New Rating from Roth MKM | LB Pharmaceuticals, Inc. (LBRX) has received a Buy rating and a price target of $31.00 from Roth MKM analyst Boobalan Pa | [Link](https://longbridge.com/zh-HK/news/272027134.md) |
| Evercore ISI Sticks to Their Buy Rating for CVS Health (CVS) | Evercore ISI analyst Elizabeth Anderson maintained a Buy rating on CVS Health (CVS) with a price target of $100.00. Ande | [Link](https://longbridge.com/zh-HK/news/275622408.md) |
| Berenberg Bank Reaffirms Their Buy Rating on Novo Nordisk (0QIU) | Berenberg Bank analyst Kerry Holford has reaffirmed a Buy rating on Novo Nordisk (0QIU) with a price target of DKK360.00 | [Link](https://longbridge.com/zh-HK/news/275719942.md) |
| J.P. Morgan Reaffirms Their Buy Rating on Sartorius (0NIR) | J.P. Morgan analyst Richard Vosser has reaffirmed a Buy rating on Sartorius (0NIR) with a price target of €295.00. Vosse | [Link](https://longbridge.com/zh-HK/news/275586209.md) |
| What 5 Analyst Ratings Have To Say About Mohawk Industries | Mohawk Industries (NYSE:MHK) received mixed ratings from 5 analysts, with an average 12-month price target of $121.2, re | [Link](https://longbridge.com/zh-HK/news/275665682.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。